Biotonix: Annual and Special Meeting of Shareholders


BROSSARD, QUEBEC--(Marketwire - May 24, 2011) - Biotonix (2010) Inc. (TSX VENTURE:BTX) ("Biotonix"), a leader in postural health and fitness, announced today agenda details of its annual and special meeting of shareholders:

DATE:Thursday, May 26, 2011
TIME:10:30 am to 11:30 am EST
PLACE:Biotonix
7055, boul. Taschereau, suite 502, Québec
Salle 2

AGENDA

Brian Edwards, Chairman of the Board of Directors, will host the formal segment of the meeting. Louise St-Onge, CEO, will present the company as well as an overview of activities and the 2011-2013 outlook.

ABOUT BIOTONIX

Biotonix (TSX VENTURE:BTX) offers innovative health solutions for posture correction and fitness using a web-based imaging software technology. Biotonix is currently developing novel orthotics for the back and foot, also geared specifically toward improving posture. For more information please visit www.biotonix.com.

BIOTONIX'S FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. There is a risk that expectations and forward looking statements will not prove to be accurate. Readers are cautioned not to place undue reliance on these forward looking statements as they involve risks and uncertainties, which could make actual results differ materially from those projected herein and depend on a number of factors including, but not limited to, no history of profitability, future financing, intellectual property and patents, key personnel, competitive marketplace, technology obsolescence, share price volatility and other risks detailed from time to time in the Company's filings. While Biotonix anticipates that subsequent events and developments may cause its views to change, Biotonix specifically disclaims any obligation to update these forward looking statements, unless obligated to do so by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:

Biotonix
Louise St-Onge
CEO
514.840.0004 ext 229
stongel@biotonix.com
www.biotonix.com